secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K/A
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001193125-26-197609
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TuHURA corrects pro forma financials for Kineta merger; FY2025 net loss $34.6M
------------------------------------------------------------------------------

- Corrected unaudited pro forma combined net loss for FY2025: $34.5M ($34.6M attributable to common), EPS -$0.66.
- Prior 8-K filed April 8, 2026 contained errors; this amendment replaces Exhibit 99.1 entirely.
- Merger with Kineta closed June 30, 2025; Kineta stockholders received 3.998M shares (7.6% of combined entity).
- TuHURA issued 4.76M shares + warrants in a June 2025 PIPE for net proceeds of $11.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000119312526197609/0001193125-26-197609-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000119312526197609/d150994d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-197609

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer